Skip to content
Unrated Drug recall · FDA · Published May 22, 2015

Novartis Recalls Foradil Aerolizer Capsules Due to Stability Failure

Novartis recalls Foradil Aerolizer (12 mcg) due to failed particle size distribution stability testing. Check lot F0082, exp May 2015.

🇺🇸 FDA recall #D-1138-2015DrugNovartis ›
Take action

Contact the company

Recalling firmNovartis Pharmaceuticals Corp.25 Old Mill Rd · Suffern, NY 10901-4106
✎ GovInfoNow plain-language explainer

What happened, in plain English

Novartis Pharmaceuticals Corp. is recalling Foradil Aerolizer inhalation powder capsules because they failed a stability specification test for particle size distribution. This recall affects 55,442 packs distributed in New Jersey via one distributor. The record does not specify any immediate physical injury risk or provide a remedy for consumers. Read more at govinfonow.com/recall/44668-novartis-pharmaceuticals-corp-recalls-foradil-aerolizer-formoterol-fumarate-inhalation-powder.

Source Summary by GovInfoNow · govinfonow.com/recall/44668-novartis-pharmaceuticals-corp-recalls-foradil-aerolizer-formoterol-fumarate-inhalation-powder · Updated October 12, 2026 · FDA enforcement record: FDA #D-1138-2015

Cite this page

“Novartis Recalls Foradil Aerolizer Capsules Due to Stability Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44668-novartis-pharmaceuticals-corp-recalls-foradil-aerolizer-formoterol-fumarate-inhalation-powder. Based on FDA recall #D-1138-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1138-2015%22&limit=1).

Why it’s dangerous

The product failed to meet stability specifications during testing, resulting in out-of-specification results for the particle size distribution test. The record does not explain how this failure affects the drug's efficacy or safety for the user.

Who’s affected

Patients who have been prescribed Foradil Aerolizer and purchased the affected packs from the specific New Jersey distributor. Individuals with the lot number F0082 and expiration date of May 2015 are specifically impacted.

How to tell if you have this one

Look for Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule, sold in packs of 60 capsules (blister strips of 6). Check if the lot number is F0082 and the expiration date is May 2015.

  • Brand
    Novartis
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    NJ via 1 distributor
Recall numberProduct, codes & lotsQuantity
D-1137-2015Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule, 12 Capsules (Blister strips of 6) per pack. For inhalation use only, Rx only, Manufactured for: Merck Sharp & Dohme Corp., a subsidiary of MERCK & CO., INC. Whitehouse Station, NJ 08889. Manufactured by: Novartis Pharma AG Basle,Via Serafino Balestra 31 Locarno, Switzerland.; Lot #: F8011, Exp May 201519,658 packs
D-1138-2015Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule, 60 Capsules (Blister strips of 6) per pack. For inhalation use only, Rx only, Manufactured for: Merck Sharp & Dohme Corp., a subsidiary of MERCK & CO., INC. Whitehouse Station, NJ 08889. Manufactured by: Novartis Pharma AG Basle,Via Serafino Balestra 31 Locarno, Switzerland.; Lot#: F0082, Exp May 201555,442 packs

Where it went and when

Where it was distributed

Distributed in New Jersey.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: yesNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “NJ via 1 distributor” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Jersey.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: May 22, 201512. FDA classified it Class III: Jun 15, 201523. Published in FDA’s Enforcement Report: Jun 24, 201534. FDA terminated the recall: May 18, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Novartis recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1138-2015 (May 22, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1138-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA